A visualization analysis of immune-related adverse reactions in pulmonary carcinoma

被引：0
作者：
Gong, Yifan [1 ]
Kang, Jianping [2 ]
Wang, Mingting [3 ]
Hayati, Mohd Firdaus Mohd [1 ]
Goh, Lucky Poh Wah [4 ]
Rahim, Syed Sharizman Bin Syed Abdul [1 ]
机构：
[1] Univ Malaysia Sabah, Fac Med & Hlth Sci, Kota Kinabalu 88450, Sabah, Malaysia
[2] Yunnan Canc Hosp, Orthoped Ward 2, Kunming, Peoples R China
[3] Panzhihua Univ, Affiliated Hosp, Oncol Dept, Panzhihua, Peoples R China
[4] Univ Malaysia Sabah, Fac Sci & Nat Resources, Kota Kinabalu, Malaysia
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2024年 / 20卷 / 01期
关键词：
Pulmonary carcinoma; immune; adverse events; Bibliometrics; visualization analysis; CELL LUNG-CANCER; CHECKPOINT BLOCKADE; MICROBIOTA; RADIOTHERAPY; TOXICITY; THERAPY;
D O I：
10.1080/21645515.2024.2429237
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Immunotherapy has emerged as a crucial advancement in pulmonary carcinoma treatment. Nevertheless, its unique side effects not only reduce patients' quality of life but also affect treatment efficacy, with severe cases potentially endangering the patient's life. This study uses bibliometric analysis to perform a comprehensive bibliometric analysis literature on IRAEs in lung cancer from 1991 to 2023, retrieved from the Web of Science database. The dataset was analyzed using VOSviewer and CiteSpace to identify trends, key contributors, and emerging research areas. A total of 124 publications were analyzed, revealing a notable increase in research activity post-2015, with China and the USA contributing over 50% of the studies. This research highlights the importance of understanding IRAEs and suggests future investigations into the pulmonary microbiota and tumor microenvironment.
引用
收藏
页数：10
相关论文
共 50 条
  • [41] Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy
    Finazzi, T.
    Rordorf, T.
    Ikenberg, K.
    Huber, G. F.
    Guckenberger, M.
    Schueler, H. I. Garcia
    [J]. BMC CANCER, 2018, 18
  • [42] Role of B cells in immune-related adverse events following checkpoint blockade
    Dhodapkar, Kavita M.
    Duffy, Alyssa
    Dhodapkar, Madhav V.
    [J]. IMMUNOLOGICAL REVIEWS, 2023, 318 (01) : 89 - 95
  • [43] Immune-Related Adverse Events of Genitourinary Cancer Patients, a Retrospective Cohort Study
    Hunting, John C.
    Deyo, Logan
    Olson, Eric
    Faucheux, Andrew T.
    Price, Sarah N.
    Lycan Jr, Thomas W.
    [J]. CANCERS, 2024, 16 (17)
  • [44] C-reactive protein as an early marker of immune-related adverse events
    Abolhassani, Amir-Reza
    Schuler, Gerold
    Kirchberger, Michael Constantin
    Heinzerling, Lucie
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (10) : 2625 - 2631
  • [45] Meta-analysis of immune-related adverse events of immune checkpoint inhibitor therapy in cancer patients
    Song, Peng
    Zhang, Dingding
    Cui, Xiaoxia
    Zhang, Li
    [J]. THORACIC CANCER, 2020, 11 (09) : 2406 - 2430
  • [46] An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis
    Liang, Kai-li
    Tackett, Sean
    Myers, Samantha
    Brahmer, Julie R.
    Browner, Ilene S.
    Ettinger, David S.
    Forde, Patrick M.
    Hales, Russell K.
    Hann, Christine L.
    Lam, Vincent K.
    Marrone, Kristen A.
    Patel, Tricia
    Peterson, Valerie
    Sagorsky, Sarah
    Turner, Michelle
    Voong, Khinh R.
    Naidoo, Jarushka
    Feliciano, Josephine L.
    [J]. CURRENT ONCOLOGY, 2022, 29 (06) : 4342 - 4353
  • [47] Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
    Cook, Sarah
    Samuel, Vanessa
    Meyers, Daniel E.
    Stukalin, Igor
    Litt, Ishjot
    Sangha, Randeep
    Morris, Don G.
    Heng, Daniel Y. C.
    Pabani, Aliyah
    Dean, Michelle
    Navani, Vishal
    [J]. JAMA NETWORK OPEN, 2024, 7 (01) : E2352302
  • [48] Safety of thoracic radiotherapy in patients with prior immune-related adverse events from immune checkpoint inhibitors
    Shaverdian, N.
    Beattie, J.
    Thor, M.
    Offin, M.
    Shepherd, A. F.
    Gelblum, D. Y.
    Wu, A. J.
    Simone, C. B., II
    Hellmann, M. D.
    Chaft, J. E.
    Rimner, A.
    Gomez, D. R.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 (12) : 1719 - 1724
  • [49] Cutaneous Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors and Their Management
    Pach, J.
    Leventhal, J. S.
    [J]. CRITICAL REVIEWS IN IMMUNOLOGY, 2022, 42 (04) : 1 - 20
  • [50] Checkpoint Inhibitors Common immune-related adverse events and their management
    Gordon, RuthAnn
    Kasler, Mary Kate
    Stasi, Kristen
    Shames, Yelena
    Errante, Mimma
    Ciccolini, Kathryn
    Lucas, Anna Skripnik
    Raasch, Pam
    Fischer-Cartlidge, Erica
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2017, 21 (02) : 45 - 52
12345